Table of Contents
ISRN Endocrinology
Volume 2013 (2013), Article ID 346987, 5 pages
http://dx.doi.org/10.1155/2013/346987
Research Article

Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice

1Laboratory of Immunobiology for Research and Diagnosis (LIRAD-BST), Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, 08916 Badalona, Spain
2Department of Endocrinology, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, 08916 Badalona, Spain
3Immunology Unit, Department of Ciencies Basiques Mediques, Faculty of Medicine, University of Lleida & IRBLleida, 25198 Lleida, Spain

Received 6 February 2013; Accepted 22 February 2013

Academic Editors: C. Anderwald and H.-Q. Qu

Copyright © 2013 Irma Pujol-Autonell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Irma Pujol-Autonell, Rosa M. Ampudia, Pau Monge, et al., “Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice,” ISRN Endocrinology, vol. 2013, Article ID 346987, 5 pages, 2013. doi:10.1155/2013/346987